People: Alnylam Pharmaceuticals Inc (ALNY.O)
23 Sep 2016
Dr. John M. Maraganore, Ph.D., is Chief Executive Officer, Director of the Company. Dr. Maraganore also served as our President from December 2002 to December 2007. From April 2000 to December 2002, Dr. Maraganore served as Senior Vice President, Strategic Product Development for Millennium Pharmaceuticals, Inc., a biopharmaceutical company (now a wholly-owned subsidiary of Takeda Pharmaceutical Company Limited). He also serves as a director of Agios Pharmaceuticals, Inc., bluebird bio, Inc. and the Biotechnology Industry Organization, a non-profit biotechnology trade organization, and formerly served as a director of Regulus Therapeutics Inc.
|Total Annual Compensation, USD||1,130,040|
|Restricted Stock Awards, USD||--|
|Long-Term Incentive Plans, USD||--|
|All Other, USD||7,131,110|
|Fiscal Year Total, USD||8,261,160|